Experience and innovation in
the manufacture of APIs

About us

More than 50 years providing solutions for the pharmaceutical industry.

Interquim is a Mexican pharmaceutical chemical company specialized in the manufacturing of Active Pharmaceutical Ingredients (APIs).
Headquartered in Mexico and guided by an internationally oriented leadership team, we have established ourselves as a global reference in the production of vitamin B12 derivatives, antibiotics, and high value-added molecules for the pharmaceutical industry. Our multidisciplinary team works with a strong commitment to innovation and the development of new products. We provide a solid scientific foundation, supported by comprehensive technical and regulatory expertise, ensuring our clients receive reliable, efficient solutions aligned with the highest quality standards.
cornerstones

Our Vision, mission, and values

Vision

To be a trusted partner in the field of active ingredient manufacturing, achieving sustained and profitable growth, and focusing on setting ourselves apart from the competition by complying with international and national standards.

Mission

To manufacture high-quality active pharmaceutical ingredients to support the growth of the international and domestic pharmaceutical industry.

Values

history

Interquim through the years

Currently

  • Interquim was acquired in December 2021 by a Mexican private equity fund.
  • The construction of a second small-scale plant was recently completed to expand production capacity for small molecules.
  • A new strategic focus has been established, centered on customized manufacturing and the development of strategic partnerships.

2015. Creating new international opportunities

  • International executives joined the company’s leadership team.
  • We positioned ourselves as leaders in the production of vitamin B12 derivatives and niche products.
  • A gram-scale pilot laboratory was built for GMP clinical trial materials.
  • We created new opportunities for established products and new molecules.

2001. Relocation of the plant to a new site

  • 2001: Relocation of the manufacturing plant to a new site.
  • 2001: Interquim moved to its current location.
  • 2005: A small-scale production plant was constructed.
  • 2012: Greater focus was placed on the vitamin B12 production line with the construction of a plant dedicated specifically to this purpose.

1970. Interquim is founded

  • Interquim was founded in 1970 and was acquired in 1984 by a Swiss-Italian family, focusing on the production of vitamin B12 derivatives.

Actualmente
  • Interquim fue adquirida en diciembre de 2021 por un fondo de capital privado mexicano.
  • Recientemente se completó la construcción de una segunda planta a pequeña escala para aumentar la capacidad de producción de moléculas pequeñas.
  • Se genera un nuevo enfoque centrado en la personalización de fabricación y establecer asociaciones estratégicas.
  • Se incorporan directivos internacionales a la compañía.
  • Nos posicionamos líderes en la producción de derivados de vitamina B12 y productos de nicho.
  • Se construye un laboratorio piloto a escala de gramal para productos de ensayo clínico GMP.
  • Creamos nuevas oportunidades para productos establecidos y nuevas moléculas.
  • 2001: Interquim es trasladada a la ubicación actual.
  • 2005: Se construye una planta de producción a pequeña escala.
  • 2012: Se incrementa el enfoque en la línea de producción de vitamina B12 mediante la construcción de una planta dedicada específicamente a este fin.
  • Interquim fue fundada en 1970 y en 1984 fue adquirida por una familia suizo-italiana, centrándose en la producción de derivados de la vitamina B12.